Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Keenova Therapeutics plc
13G
MNKTQ · G5890A102
|
5.5% |
2/13/2026
Event 12/31/2025
|
|||
| Hein Park Capital Management LP | 5.5% | ||||
| Hein Park Capital Management GP LLC | 5.5% | ||||
| Courtney W. Carson | 5.5% | ||||
|
Mallinckrodt plc
13D/A
Amendment 5
MNKTQ · G5890A102
|
4.9% |
8/4/2025
Event 7/31/2025
|
|||
| Hein Park Capital Management LP | 4.9% | ||||
| Hein Park Capital Management GP LLC | 4.9% | ||||
| Courtney W. Carson | 4.9% | ||||
|
DIEBOLD NIXDORF, Inc
13D/A
Amendment 4
DBD · 253651202
|
4.1% |
5/19/2025
Event 5/15/2025
|
|||
| Hein Park Capital Management LP | 4.1% | ||||
| Hein Park Capital Management GP LLC | 4.1% | ||||
| Courtney W. Carson | 4.1% | ||||
|
Mallinckrodt plc
13D/A
Amendment 4
MNKTQ · G5890A102
|
9.7% |
3/17/2025
Event 3/13/2025
|
|||
| Hein Park Capital Management LP | 9.7% | ||||
| Hein Park Capital Management GP LLC | 9.7% | ||||
| Courtney W. Carson | 9.7% | ||||